Scandion Oncology AS Performance
Scandion Oncology Relative Risk vs. Return Landscape
If you would invest (100.00) in Scandion Oncology AS on October 17, 2025 and sell it today you would earn a total of 100.00 from holding Scandion Oncology AS or generate -100.0% return on investment over 90 days. Scandion Oncology AS is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than Scandion, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Scandion Oncology Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Scandion Oncology's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Scandion Oncology AS, and traders can use it to determine the average amount a Scandion Oncology's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| High Returns | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| SCOL |
Based on monthly moving average Scandion Oncology is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Scandion Oncology by adding Scandion Oncology to a well-diversified portfolio.
Things to note about Scandion Oncology performance evaluation
Checking the ongoing alerts about Scandion Oncology for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Scandion Oncology help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Scandion Oncology is not yet fully synchronised with the market data | |
| Scandion Oncology has some characteristics of a very speculative penny stock |
- Analyzing Scandion Oncology's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Scandion Oncology's stock is overvalued or undervalued compared to its peers.
- Examining Scandion Oncology's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Scandion Oncology's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Scandion Oncology's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Scandion Oncology's stock. These opinions can provide insight into Scandion Oncology's potential for growth and whether the stock is currently undervalued or overvalued.
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Other Consideration for investing in Scandion Stock
If you are still planning to invest in Scandion Oncology check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Scandion Oncology's history and understand the potential risks before investing.
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data |